$397.48
$0.00 (0.00%)
End-of-day quote: 04/27/2024
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$9.87B | $8.93B | $7.57B | $102.72M | $160.89M | $216.36M | $199.01M | $175.50M | $101.89M | $143.37M | $1.41B | $1.53B | $1.21B | $580.42M | $1.03B | $1.70B | $2.49B | $3.05B | $4.16B | $6.21B | |
| GM % | Gross Margin % |
|
55.16% | 59.60% | 47.78% | 6.42% | 6.52% | -80.90% | -40.65% | 2.18% | -60.18% | -17.69% | 44.12% | 31.52% | 16.47% | -57.90% | -8.53% | 26.09% | 35.72% | 40.08% | 44.69% | 58.65% | |
| OM | Operating Margin |
|
43.65% | 49.03% | 36.69% | -133.60% | -88.10% | -104.17% | -207.36% | -261.18% | 0.00% | 0.00% | 15.72% | 3.18% | -12.92% | -110.52% | -45.01% | 0.66% | 15.78% | 21.79% | 28.87% | 46.24% | |
| EPS | Earnings Per Share |
|
$0.00 | $15.23 | $14.88 | $13.02 | $10.32 | $5.33 | $4.08 | $1.95 | $0.85 | $-1.11 | $-2.17 | $-1.58 | $1.18 | $-0.50 | $-3.48 | $-3.64 | $-3.27 | $-3.03 | $-1.86 | $-1.65 | $-1.85 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0.00% | 0.00% | 0.00% | 0 | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0.00% | -0.00% | -0.00% | -0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Sha. | Shares |
|
257.7m | 257.01m | 254.48m | 80.76m | 108.15m | 126.12m | 132.88m | 151.25m | 199.96m | 203.52m | 209.3m | 217.29m | 233.79m | 241.76m | 246.31m | 248.3m | 253.25m | 255.17m | 258.99m | 259.89m | |
| OCF | Operating Cash Flow |
|
$3.54B | $4.13B | $2.64B | $-142.12M | $-172.05M | $-22.48M | $-252.48M | $-226.48M | $-427.59M | $-635.44M | $143.74M | $267.84M | $-60.67M | $-573.11M | $-365.43M | $236.10M | $844.94M | $1.27B | $1.57B | $3.25B | |
| FCF | Free Cash Flow |
|
$3.53B | $3.93B | $2.41B | $-154.66M | $-189.01M | $-54.90M | $-284.90M | $-258.66M | $-451.09M | $-673.50M | $109.14M | $196.70M | $-102.96M | $-564.40M | $-410.73M | $179.54M | $745.52M | $1.17B | $1.49B | $2.99B | |
| FCFS | Free Cash Flow Per Share |
|
$12.72 | $15.33 | $9.35 | $-1.97 | $-2.12 | $-0.48 | $-2.21 | $-1.84 | $-2.60 | $-3.36 | $0.53 | $0.93 | $-0.76 | $-2.65 | $-2.03 | $0.73 | $2.35 | $4.62 | $5.82 | $11.52 |
